Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Futu Holdings Ltd (FUTU) vs TransMedics Group Inc (TMDX) Price & Performance

Futu Holdings LtdTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Futu Holdings Ltd vs TransMedics Group Inc — how do they compare? Futu Holdings Ltd trades at $105.34 (market cap $14.74B), while TransMedics Group Inc trades at $87.46 (market cap $3.10B). The key difference: Futu Holdings Ltd is far larger — about 4.8× TransMedics Group Inc's market cap, and Futu Holdings Ltd pays a 2.47% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

FUTUTMDX
Market Cap
$14.74B$3.10B
Sector
FinancialsTechnology
52-Week High
$199.04$150.42
52-Week Low
$89.76$61.99
Enterprise Value
$14.59B$3.49B
Dividend Yield
2.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Futu Holdings Ltd

Futu Holdings Limited (FUTU) trades at $108.70, showing modest daily movement with a slight decline of 0.29%. The stock exhibits a bullish technical trend, supported by moving averages, while recent earnings have been mixed with two misses and one beat against expectations. Strong revenue growth and profitability margins highlight solid fundamental performance, though the company faces significant legal and regulatory scrutiny.

The outlook for FUTU is cautiously optimistic, driven by robust financial health and analyst support, but overshadowed by ongoing securities class action lawsuits alleging regulatory compliance failures. Key risks include legal liabilities and market sentiment pressure, while opportunities lie in sustained earnings growth and favorable valuation metrics.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.

Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.

Returns comparison

Trailing returns across standard periods

About Futu Holdings Ltd

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.

Read more on FUTU

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX